Canadian Partnership Against Cancer Announces Inaugural Board
TORONTO, April 25 – The first Board of Directors for the Canadian Partnership Against Cancer was announced today by Board Chair Jeff Lozon. The Partnership, funded by the federal government, is the first body to bring together patient survivors, cancer experts and government representatives from across the country to lead the implementation of a national cancer strategy.
The Partnership represents years of work by a coalition with representatives from cancer organizations, the research community, patients and families, aboriginal organizations and government who developed the Canadian Strategy to Control Cancer.In late 2006, the independent corporation was announced by Prime Minister Stephen Harper with Jeff Lozon, President and CEO of St. Michael’s Hospital of Toronto appointed as chair. Noted cancer specialist Dr. Simon Sutcliffe, President and CEO of BC Cancer Care, Vancouver, was announced as vice-chair.
“Last year, Prime Minister Harper delivered on a commitment to establish Canada’s firstever national organization to implement a cancer control strategy, which is predicted to pre-empt 1.2 million new cases of cancer and prevent 423,000 cancer deaths over the next 30 years,” said Health Canada Minister Tony Clement who championed the strategy within the federal government. “This initiative is the first complete and well co-ordinated approach to control cancer in Canada, and with the Board of Directors for this organization now selected their important work can begin.”
The Board of Directors comprises representatives from the country’s five regions, cancer patient/survivors as well as a cross section of the cancer care community from across the country.
“Everyone who has ownership of the results of the cancer control strategy will be at the table – from patients and survivors to government policy makers, doctors, specialists and researchers, “ said Mr. Lozon. “ We have an outstanding inaugural board ready to take on the task.”
They are Chris Clark, Toronto, Ontario; Peter Crossgrove, Toronto, Ontario; Dr. Lindsay Crowshoe, Piikani Nation, Alberta; Dr. Louis Dionne, Quebec City, Que., René Gallant, Hammonds Plains, Nova Scotia; Dr. Perry Kendall, Victoria, BC; Joy Maddigan, St. John’s , NFLD, Paddy Meade, Edmonton, Alta; Gary Semenchuck, Regina, Sask.;Dr. Marla Shapiro, Toronto, Ontario; Terry Sullivan, PhD, Toronto, Ont.; Laura M. Talbot, Kingston, Ontario; Sally Thorne, Vancouver, BC, Elizabeth Whamond, New Brunswick; Barbara Whylie, Toronto; Arlene Wilgosh, Winnipeg, Man.
The Partnership is finalizing arrangements with Quebec for observer status.
“I’m honored to join the Board of Directors,” said Dr. Barbara Whylie, CEO, Canadian Cancer Society. “Together we will work to implement the Strategy and make a real difference in the lives of Canadians and people living with cancer.”
The first meeting of the Board of Directors will be held in May.
The federal government is investing $260 million in funding over five years to implement the cancer strategy.
For more information please contact:
Lee Allison Howe
~ Backgrounder Board Biographies